Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...

Modeling data show Cologuard Plus TM test delivers highest life-years gained with fewest number of colonoscopies among noninvasive colorectal cancer (CRC) screening strategies Additional abstracts ...

ACG abstracts are available on the meeting website. “Exact Sciences is pleased to share new modeling data which demonstrates the Cologuard Plus test as an efficient CRC screening strategy across ...

With various DStv packages with the channels listed on offer, what are their differences and prices, and how do you choose the best one for you? DStv gives subscribers the best personal and family ...

Multitarget stool DNA test (Cologuard) This combines testing for ... colon cancer tests require you to collect some of your poop, package it up, and send it to a lab or your doctor's office.

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults aged 45 years at average risk for colorectal cancer. The Food and Drug Administration (FDA) has approved the ...

Exact Sciences EXAS recently received FDA approval for its next-generation multitarget stool DNA test, Cologuard Plus. This marks a significant advancement for the company in the field of ...

The endorsement follows the recent approval by the FDA of Cologuard Plus, Exact Sciences' enhanced stool test for colorectal cancer screening. The approval, which was anticipated by both the analyst ...

Mark Massaro has given his Buy rating due to a combination of factors including the recent FDA approval and anticipated superior performance of Exact Sciences’ Cologuard Plus test. The analyst ...

Cologuard Plus™ test raises the performance bar with sensitivities of 95% for colorectal cancer and 43% for advanced precancerous lesions at 94% specificity Cologuard Plus test will minimize ...

Puneet Souda’s rating is based on the expectation of broader adoption and higher volumes for Exact Sciences’s Cologuard Plus (CG+), which is anticipated to have higher specificity compared to ...